Hepatic amyloidosis resulting from deposition of the apolipoprotein A-I variant Leu75Pro

References

• Benson M D. The metabolic and molecular bases of inherited disease. Amyloidosis8th ed., A L Beaudet, W S Sly, D Valle. McGraw Hill, New York 2001; 5345–5378
   Google Scholar
• Nichols W C, Gregg R E, Brewer H B, Jr., Benson M D. A mutation in apolipoprotein A‐1 in the Iowa type of familial amyloidotic polyneuropathy. Genomics 1990; 8: 318–323
   PubMed Web of Science ®Google Scholar
• Vigushin D M, Gough J, Allan D, Alguacil A, Penner B, Pettigrew N M, Quinonez G, Bemstein K, Booth S E, Booth D R, Soutar A K, Hawkins P N, Pepys M B. Familial nephropathic systemic amyloidosis caused by apolipoprotein A1 variant Arg 26. Q J Med 1994; 87: 149–154
   PubMedGoogle Scholar
• Jones L A, Harding J A, Cohen A S, Skinner M. New USA family has apolipoprotein A1 (Arg 26) variant. Amyloid and Amyloidosis, J B Natvig, OS Forrem, G Husby, A Husebekk, B Skogen, K Sletten, P Westermark. Kluwer Academic Publishers, Dordrecht 1990; 385–388
   Google Scholar
• Soutar A K, Hawkins P N, Vigushin D M, Tennent G A, Booth S E, Hutton T, Nguyen O, Totty N F, Feest T G, Hsuan J J, Pepys M B. Apolipoprotein AI mutation Arg‐60 causes autosomal dominant amyloidosis. Proc Natl Acad Sci USA. 1992; 89: 7389–7393
   PubMed Web of Science ®Google Scholar
• Booth D R, Tan S ‐Y, Booth S E, Hsuan J J, Totty N F, Nguyen O, Hutton T, Vigushin D M, Tennent G A, Hutchinson W L, Thomson N, Soutar A K, Hawkins P N, Pepys M B. A new apolipoprotein A1 variant, Trp50Arg, causes hereditary amyloidosis. Q J Med 1995; 88: 695–702
   Google Scholar
• Booth D R, Tan S ‐Y, Booth S E, Tennent G A, Hutchinson W L, Hsuan J J, Totty N F, Truong O, Soutar A K, Hawkins P N, Bruguera M, Caballeria J, Sole M, Campistol J M, Pepys M B. Hereditary hepatic and systemic amyloidosis caused by a new deletionhsertion mutation in the apolipoprotein A1 gene. J Clin Invest 1996; 97: 2714–2721
   PubMed Web of Science ®Google Scholar
• Caballeria J, Bruguera M, Sole M, Campistol J M, Rodes J. Hepatic familial amyloidosis caused by a new mutation in the apolipoprotein A1 gene: clinical and pathologic features. Am J Gastroenterol 2001; 96: 1872–1876
   PubMed Web of Science ®Google Scholar
• Persey M R, Booth D R, Booth S E, van Zyl‐Smit R, Adams B K, Fattaar A B, Tennent G A, Hawkins P N, Pepys M B. Hereditary nephropathic systemic amyloidosis caused by a novel variant apolipoprotein A‐I. Kidney Int 1998; 53: 276–281
   PubMed Web of Science ®Google Scholar
• Hamidi As1 L, Liepnieks J J, Hamidi As1 K, Uemichi T, Moulin G, Desjoyaux E, Loire R, Delpech M, Grateau G, Benson M D. Hereditary amyloid cardiomyopathy caused by a variant apolipoprotein A1. Am J Pathol 1999; 154: 221–227
   PubMedGoogle Scholar
• Hamidi Asl K, Liepnieks J J, Nakamura M, Parker F, Benson M D. A novel apolipoprotein A‐1 variant, Arg173Pro, associated with cardiac and cutaneous amyloidosis. Biochem Biophys Res Commun 1999; 57: 584–588
   Google Scholar
• Obici L, Bellotti V, Mangione P, Stoppini M, Arbustini E, Verga L, Zorzoli I, Anesi E, Zanotti G, Campana C, Vigano M, Merlini G. The new apolipoprotein A‐I variant Leu(174) Ser causes hereditary cardiac amyloidosis, and the amyloid fibrils are constituted by the 93‐residue N‐terminal polypeptide. Am J Pathol 1999; 155: 695–702
   PubMed Web of Science ®Google Scholar
• Mangione P, Sunde M, Giorgetti M S, Stoppini M, Esposito G, Gianelli L, Obici L, Asti L, Andreola A, Viglino P, Merlini G, Bellotti V. Amyloid fibrils derived from the apolipoprotein A1 Leu174Ser variant contain elements of ordered helical structure. Protein Sci 2001; 10: 187–199
   PubMed Web of Science ®Google Scholar
• de Sousa M M, Vital C, Ostler D, Femandes R, Pouget‐Abadie J, Carles D, Saraiva M J. Apolipoprotein A1 and transthyretin as components of amyloid fibrils in a kindred with Apo AI Leu178 His amyloidosis. Am J Pathol 2000; 156: 1911–1917
   PubMed Web of Science ®Google Scholar
• Mucchiano G I, Haggqvist B, Sletten K, Westermark P. Apolipoprotein A‐1– derived amyloid in atherosclerotic plaques of the human aorta. J Pathol 2001; 93: 270–275
   Google Scholar
• Johnson K H, Sletten K, Hayden D W, O'Brien T D, Roertgen K E, Westermark P. Pulmonary vascular amyloidosis in aged dogs. A new form of spontaneously occurring amyloidosis derived from apolipoprotein AI. Am J Pathol 1992; 141: 1013–1019
   PubMed Web of Science ®Google Scholar
• Obici L, Palladini G, Perfetti V, Marciano S, Bruno M, Giorgetti S, Bellotti V, Arbustini E, Merlini G. Molecular characterization of hereditary systemic amyloidosis in Italy: Identification of a novel apolipoprotein A1 variant with predominately hepatic phenotype. Amyloid and Arnyloidosis. The Proceedings of the IXth International Symposium on Amyloidosis, M Bély, A Apáthy. David Apathy, Hungary 2001; 81–83
   Google Scholar
• Murphy C L, Eulitz M, Hmcic R, Sletten K, Westermark P, Williams T, Macy S D, Wooliver C, Wall J, Weiss D T, Solomon A. Chemical typing of amyloid protein contained in formalin‐fixed paraffin‐embedded biopsy specimens. Am J Clin Pathol 2001; 116: 135–142
   PubMed Web of Science ®Google Scholar
• Seilhamer J J, Protter A A, Frossard P, Levy‐Wilson B. Isolation and DNA sequence of full‐length cDNA and of the entire gene for human apolipoprotein AI‐discovery of a new genetic polymorphism in the apo AI gene. DNA 1984; 3: 309–317
   PubMedGoogle Scholar
• Rader D J, Gregg R E, Meng M S, Schaefer J R, Zech L A, Benson M D, Brewer H B, Jr. In vivo metabolism of a mutant apolipoprotein, Apo A‐I IOWA, associated with hypoalphalipoproteinemia and hereditary systemic amyloidosis. J Lipid Res 1992; 33: 755–763
   PubMed Web of Science ®Google Scholar
• Tilly‐Kiesi M, Packard C J, Kahri J, Ehnholm C, Shepherd J, Taskinen M R. In vivo metabolism of Apo A‐I and Apo A‐II in subjects with Apo A‐I(Lys 1070) associated with reduced HDL cholesterol and Lp(AI w AII) deficiency. Atherosclerosis 1997; 128: 213–222
   PubMed Web of Science ®Google Scholar
• Genschel J, Haas R, Propsting M J, Schmidt H ‐H. Apolipoprotein A‐I induced amyloidosis. FEBS Lett 1998; 30: 145–149
   Google Scholar
• Amarzguioui M, Mucchiano G, Haggqvist B, Westermark P, Kavlie A, Sletten K, Prydz H. Extensive intimal apolipoprotein A1‐derived amyloid deposits in a patient with an apolipoprotein A1 mutation. Biochem Biophys Res Commun 1998; 242: 534–539
   PubMed Web of Science ®Google Scholar
• Westermark P, Mucchiano G, Marthin T, Johnson K H, Sletten K. Apolipoprotein A1‐derived amyloid in human aortic atherosclerotic plaques. Am J Pathol 1995; 147: 1186–1192
   PubMed Web of Science ®Google Scholar
• Westermark P, Sletten K, Johansson B, Cornwell G G, 3rd. Fibril in senile systemic amyloidosis is derived from normal transthyretin. Proc Natl Acad Sci USA 1990; 87: 2843–2845
   PubMed Web of Science ®Google Scholar
• Westermark P, Eriksson L, Engstrom U, Enestrom S, Sletten K. Prolactin‐derived amyloid in the aging pituitary gland. Am J Pathol 1997; 150: 67–73
   PubMed Web of Science ®Google Scholar
• Häggqvist B, Naslund J, Sletten K, Westermark G T, Mucchiano G, Tjernberg L O, Nordstedt C, Engstrom U, Westermark P. Medin: an integral fragment of aortic smooth muscle cell ‐ produced lactadherin forms the most common human amyloid. Proc Natl Acad Sci USA 1999; 96: 8669–8674
   PubMed Web of Science ®Google Scholar
• Higuchi K, Naiki H, Kitagawa K, Hosokawa M, Takeda T. Mouse senile amyloidosis. ASSAM amyloidosis in mice presents universally as a systemic age‐associated amyloidosis. Virchows Arch B Cell Pathol Incl Mol Pathol 1991; 60: 231–238
   PubMedGoogle Scholar
• Yazaki M, Liepnieks J J, Yamashita T, Guenther B, Skinner M, Benson M. Renal amyloidosis caused by a novel stop‐codon mutation in the apolipoprotein A‐II gene. Kidney Inc 2001; 60: 1658–1665
   PubMed Web of Science ®Google Scholar
• Borhani D W, Rogers D P, Engler J A, Brouillette C G. Crystal structure of truncated human apolipoprotein A‐I suggests a lipid‐bound conformation. Proc Natl Acad Sci USA 1997; 94: 12291–12296
   PubMed Web of Science ®Google Scholar
• Gylling H, Relas H, Miettinen H E, Radhakrishnan R, Miettinen T A. Delayed postprandial retinyl palmitate and squalene removal in a patient heterozygous for apolipoprotein A‐IFM mutation (Leu 159 Arg) and low HDL cholesterol level without coronary artery diseases. Atherosclerosis 1996; 127: 239–243
   PubMedGoogle Scholar
• Leren T P, Bakken K S, Daum U, Ose L, Berg K, Assmann G, von Eckardstein A. Heterozygosity for apolipoprotein A‐I (R160L)Oslo is associated with low levels of high density lipoprotein cholesterol and HDL‐subclass LpA‐I/A‐II but normal levels of HDL‐subclass LpA‐I. J Lipid Res 1997; 38: 121–131
   PubMedGoogle Scholar
• von Eckardstein A, Funke H, Walter M, Altland K, Benninghoven A, Assmann G. Structural analysis of human apolipoprotein A‐I variants. Amino acid substitutions are nonrandomly distributed throughout the apolipoprotein A‐I primary structure. J Biol Chem 1990; 265: 8610–8617
   PubMed Web of Science ®Google Scholar
• Wisniewski T, Golabek A A, Kida E, Wisniewski K E, Frangione B. Conformational mimicry in Alzheimer's disease. Role of apolipoproteins in amyloidogenesis. Am J Pathol 1995; 147: 238–244
   PubMed Web of Science ®Google Scholar
• Frank P G, Marcel Y L. Apolipoprotein A‐1: structure‐function relationships. J Lipid Res 2000; 41: 853–872
   PubMed Web of Science ®Google Scholar
• Bergeron J, Frank P G, Scales D, Meng Q H, Castro G, Marcel Y L. Apolipoprotein A‐I confirmation in reconstituted discoidal lipoproteins varying in phospholipid and cholesterol content. J Biol Chem 1995; 270: 27429–27438
   PubMed Web of Science ®Google Scholar
• Andreola A, Bellotti V, Giorgetti S, Mangione P, Obici L, Stoppini M, Torres J, Monzani E, Merlini G, Sunde M. Conformational switching and fibrillogenesis in the amyloidogenic fragment of Apolipoprotein A‐I. J Biol Chem 2003; 278: 2444–2451
   PubMed Web of Science ®Google Scholar
• Mucchiano G, Jonasson L, Häggqvist B, Einarsson E, Westermark P. Apolipoprotein A‐I (Apo A‐I) derived amyloid in atherosclerosis. Its association with plasma levels of apolipoprotein A‐I and cholesterol. Am J Clin Pathol 2001; 115: 298–303
   PubMed Web of Science ®Google Scholar
• Suresh Kumar M, Carson M, Mahmood Hussain M, Krishna Murthy H M. Structures of apolipoprotein A‐II and a lipid‐surrogate complex provide insights into apolipoprotein‐lipid interactions. Biochemistry 2002; 41: 11681–11691
   PubMedGoogle Scholar
• Calandra S, Tarugi P. Synthesis and secretion of apolipoprotein A‐I. Biochem Soc Trans 1993; 21: 493–499
   PubMedGoogle Scholar
• Gillmore J, Stangou A J, Tennent G, Booth D, O'Grady J, Rela M, Heaton N, Wall C A, Keogh J A, Hawkins P N. Clinical and biochemical outcome of hepatorenal transplantation for hereditary systemic amyloidosis associated with apolipoprotein AI Gly26Arg. Transplantation 2001; 71: 986–992
   PubMed Web of Science ®Google Scholar
• Steen L, Holmgren G, Suhr O, Wikstrom L, Groth C ‐G, Ericzon B ‐G. World‐wide survey of liver transplantation in patients with familial amyloidotic polyneuropathy. Amyloid: Int J Exp Clin Invest 1994; 1: 138–142
   Web of Science ®Google Scholar